Merck’s Ervebo Becomes World’s First Approved Ebola Vaccine
European Commission Grants Conditional Approval
Merck Sharp & Dohme will begin manufacturing licensed doses of Ervebo in Germany and will continue to send investigational vaccine doses to Democratic Republic of Congo.
